34 related articles for article (PubMed ID: 15509120)
1. Gefitinib does not increase survival in lung cancer patients.
Golsteyn RM
Drug Discov Today; 2005 Mar; 10(6):381. PubMed ID: 15808815
[No Abstract] [Full Text] [Related]
2. More haste, less speed.
Lancet Oncol; 2003 Jun; 4(6):325. PubMed ID: 12788389
[No Abstract] [Full Text] [Related]
3. Gefitinib: phoenix from the flames.
Lancet Oncol; 2009 Aug; 10(8):737. PubMed ID: 19647191
[No Abstract] [Full Text] [Related]
4. Gefitinib Approved for EGFR-Mutated NSCLC.
Cancer Discov; 2015 Sep; 5(9):896. PubMed ID: 26238462
[No Abstract] [Full Text] [Related]
5. Selection bias, phase II trials, and the FDA accelerated approval process.
George SL
J Natl Cancer Inst; 2003 Sep; 95(18):1351-2. PubMed ID: 13130101
[No Abstract] [Full Text] [Related]
6. Approved use of gefitinib.
Lyle J
Am J Health Syst Pharm; 2004 Oct; 61(19):2008; author reply 2008. PubMed ID: 15509120
[No Abstract] [Full Text] [Related]
7. The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer.
Comis RL
Oncologist; 2005 Aug; 10(7):467-70. PubMed ID: 16079313
[No Abstract] [Full Text] [Related]
8. FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Kazandjian D; Blumenthal GM; Yuan W; He K; Keegan P; Pazdur R
Clin Cancer Res; 2016 Mar; 22(6):1307-12. PubMed ID: 26980062
[TBL] [Abstract][Full Text] [Related]
9. [Gefitinib in non-small cell lung cancer].
Nakagawa K
Nihon Rinsho; 2004 Jul; 62(7):1312-20. PubMed ID: 15283149
[No Abstract] [Full Text] [Related]
10. [Molecular factors related to gefitinib efficacy in advanced non-small cell lung cancer].
Lv P; Zhou T
Zhongguo Fei Ai Za Zhi; 2010 Mar; 13(3):247-53. PubMed ID: 20673523
[No Abstract] [Full Text] [Related]
11. [Iressa (gefitinib)].
Kudoh S; Yoshimura A; Gemma A
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1079-84. PubMed ID: 12938261
[TBL] [Abstract][Full Text] [Related]
12. [Development of individualized therapy of non-small cell lung cancer targeted at the EGF receptor].
Kakiuchi S; Yano S; Sone S
Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1831-8. PubMed ID: 16223143
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]